PALATIN TECHNOLOGIES INC (PTN)
US6960775020 - Common Stock
PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
PTN stock results show that Palatin Techs missed analyst estimates for earnings per share the third quarter of 2024.
Palatin stock plunges 40% on mixed Phase 3 data for dry eye drug (NYSE:PTN)
Palatin Technologies (PTN) stock plunged 40% Wednesday after the company said a Phase 3 pivotal study for its drug PL9643 failed to meet a co-primary endpoint. Read more here.
The 3 Best Penny Stocks to Buy in February 2024
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies.
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Palatin to raise ~$10M via securities offering
Palatin (PTN) announces a registered direct offering of approximately 1.83 million shares at $5.46 per share, alongside a concurrent private placement of...
3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
These penny stocks have triple-digit upside as 2024 brings easing monetary policy and economic normalization.
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
Friday Sector Laggards: Biotechnology, Rubber & Plastics
Analysts Say 3 Stocks Have a Combined Upside of 3000%
These high-risk, high-reward bets could be at an inflection point before their growth takes off next year.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!
Palatin Technologies files to sell 2.48M shares of common stock for holders (NYSE:PTN)
Read about Palatin Technologies (PTN) filing a prospectus for the offer and sale of 2,476,416 shares of common stock by selling stockholders.
Palatin falls on common stock and warrants offering (NYSE:PTN)
Palatin Technologies (PTN) announces a direct offering of 2.358M common shares at $2.12 per share, along with warrants and a closing date of October 24,...
Palatin says preliminary Q1 gross product revenue for Vyleesi was $4.6M (NYSE:PTN)
Palatin Technologies said Thursday its preliminary gross product revenue for Vyleesi was $4.6 million for the first quarter of fiscal 2024. Read more.
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
/PRNewswire/ -- The Melanocortin Receptor 4 (MC4R) is a protein-coupled receptor primarily expressed in the central nervous system, playing a pivotal role in...
Palatin receives notice of non-compliance from NYSE American (NYSE:PTN)
Palatin Technologies receives notice of non-compliance from NYSE American due to inadequate stockholders' equity, but no immediate impact on stock trading.
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End
EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END